Peptides and Autoimmune Diseases

Several self-molecules have been identified as target antigens in autoimmune diseases. Since lack or loss of tolerance to these molecules is one of the key events promoting autoimmunity, researchers are exploring the possibility that the administration of antigens or peptides may stimulate tolerogenic mechanisms and delay or prevent the full phenotypic expression of autoimmune diseases. There is much enthusiasm for such therapies, as these will probably be disease-specific and not associated with the side effects of conventional immunosuppression

 

 

<div style="&quot;text-align:" justify;"="">

 

 

 

 

 

 

  • Thymus
  • Harnessing Treg cells
  • Designing Peptides for Therapy

Related Conference of Peptides and Autoimmune Diseases

March 04-05, 2019

10th Molecular Immunology & Immunogenetics Congress

Barcelona, Spain
March 18-19, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
March 18-19, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
April 15-18, 2019

Annual Immunology Conference 2019

Savannah, USA
June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 24-25, 2019

11th World Congress and Expo on Immunology

Vancouver, Canada
July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
October 21-22, 2019

12th Annual Congress on Immunology & Immunogenetics

Rome, Italy
November 22-23, 2019 |

World Conference on Vaccine and Immunology

Dubai, UAE

Peptides and Autoimmune Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in